Murray Stewart
Net worth: 27 511 $ as of 2026-05-30
Net worth: 27 511 $ as of 2026-05-30
Murray Willis Stewart currently works at X4 Pharmaceuticals, Inc., as Independent Director from 2023, Vivli Center For Global Clinical Research Data, as Director, VectivBio AG, as Director, and CAMP4 Therapeutics Corp., as Independent Director from 2025.
Dr. Stewart also formerly worked at Amarin Corp.
Plc, as Independent Director in 2023, VectivBio Holding AG, as Independent Director from 2021 to 2023, Rhythm Pharmaceuticals, Inc., as Chief Medical Officer from 2018 to 2021, GSK Plc, as Chief Medical Officer from 2014 to 2017, and Novelion Therapeutics, Inc., as Executive VP, Head-Research & Development from 2017 to 2018.
Dr. Stewart received his doctorate degree from The University of Southampton.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-28 | 6,383 ( 0.01% ) | 27 511 $ | 2026-05-30 | |
| 2026-06-09 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Director/Board Member | 2019-03-28 |
| CAMP4 THERAPEUTICS CORPORATION | Director/Board Member | 2025-03-17 |
Vivli Center For Global Clinical Research Data
Vivli Center For Global Clinical Research Data Internet Software/ServicesTechnology Services Operates as a clinical research data sharing platform | Director/Board Member | - |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| VECTIVBIO HOLDING AG | Director/Board Member | 2023-06-25 |
| AMARIN CORPORATION PLC | Director/Board Member | 2023-03-05 |
| RHYTHM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2021-09-09 |
| NOVELION THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2018-10-16 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 2017-10-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Vivli Center For Global Clinical Research Data
Vivli Center For Global Clinical Research Data Internet Software/ServicesTechnology Services Operates as a clinical research data sharing platform | Technology Services |
VectivBio Holding AG
VectivBio Holding AG Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for rare diseases | Health Technology |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions